SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193805-18-000608
Filing Date
2018-05-02
Accepted
2018-05-02 14:35:37
Documents
2

Document Format Files

Seq Description Document Type Size
1 e617964_sc13da-at.htm SC 13D/A 26098
2 e617964_ex-i.htm EX-99.I 11627
  Complete submission text file 0001193805-18-000608.txt   39085
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-900-2660
Arcturus Therapeutics Ltd. (Subject) CIK: 0001566049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87471 | Film No.: 18799007
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address
Payne Joseph E (Filed by) CIK: 0001727315 (see all company filings)

Type: SC 13D/A